Target intelligence / Profile preview

Dura mater of spinal cord

Molecular classification
Other
01

Overview

The **dura mater of the spinal cord** is the thick, tough, fibrous outermost membrane covering the spinal cord, comprising a single meningeal layer that forms the so-called spinal dural sac or thecal sac[1][3][6]. Unlike the cranial dura mater, which has two layers, the spinal dura mater consists only of the meningeal layer[1][3]. This membrane protects, anchors, and supports the spinal cord, forming a barrier around the central nervous system and providing an enclosure for the cerebrospinal fluid (CSF) within the subarachnoid space[1][3][5][6]. The spinal dura is not a molecular or therapeutic target in the sense of receptors, enzymes, or transporters, but rather a structural tissue that plays a critical role in neurosurgical and anesthetic procedures (e.g., spinal taps, epidural anesthesia) and may be involved in disease processes such as meningitis or spinal hematomas[3][6]. Additional notes: - As “Dura mater of spinal cord” refers to a protective tissue and not a molecular entity, receptor, or enzyme, it is not appropriate to classify it as a drug target. - Commonly encountered in anatomical and clinical contexts, but “Dura mater of spinal cord” is not a conventional or canonical name for a druggable target and does not have a widely accepted abbreviation. - Some information fields above (“interacting_drugs,” “mechanism_of_action,” “biomarkers”) are not applicable for an anatomic tissue.

Other names
Spinal dura materSpinal dural sacThecal sac
02

Mechanism of action

Not applicable

03

Biological functions

Structural protection of central nervous systemEnclosure and support of cerebrospinal fluidPhysical barrier for spinal cord
04

Disease associations

Inflammation (e.g., meningitis)Site of hematoma or abscessComplications in spinal surgery or anesthesiaOther
05

Safety considerations

Risk of infection (e.g., meningitis)Risk of bleeding (e.g., epidural or subdural hematoma)Risk of CSF (cerebrospinal fluid) leak following puncture or surgery
06

Interacting drugs

None (the dura mater is not a conventional molecular drug target, but is affected by drugs delivered epidurally or intrathecally)
07

Biomarkers

Not applicable

Beyond the preview

Go deeper on Dura mater of spinal cord.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dura mater of spinal cord.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call